Cite
HARVARD Citation
Gadaud, N. et al. (2022). Azacitidine, intensive chemotherapy or best supportive care in relapsed or refractory acute myeloid leukemia, a DATAML registry study. Leukemia & lymphoma. 63 (6), pp. 1398-1406. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gadaud, N. et al. (2022). Azacitidine, intensive chemotherapy or best supportive care in relapsed or refractory acute myeloid leukemia, a DATAML registry study. Leukemia & lymphoma. 63 (6), pp. 1398-1406. [Online].